Jones SE - Search Results

1

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

Dixon DO, Neilan B, Jones SE, Lipschitz DA, Miller TP, Grozea PN, Wilson HE. Dixon DO, et al. Among authors: jones se. J Clin Oncol. 1986 Mar;4(3):295-305. doi: 10.1200/JCO.1986.4.3.295. J Clin Oncol. 1986. PMID: 3512783 Clinical Trial.

2

Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.

Jones SE, Miller TP, Connors JM. Jones SE, et al. J Clin Oncol. 1989 Sep;7(9):1186-91. doi: 10.1200/JCO.1989.7.9.1186. J Clin Oncol. 1989. PMID: 2671279 Clinical Trial.

3

Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.

Jones SE, Grozea PN, Miller TP, Van Slyck EJ, Balcerzak SP, Costanzi JJ, Morrison FS, Eyre HJ, Fabian CJ, Dabich L, et al. Jones SE, et al. J Clin Oncol. 1985 Oct;3(10):1318-24. doi: 10.1200/JCO.1985.3.10.1318. J Clin Oncol. 1985. PMID: 3900301 Clinical Trial.

4

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI. Miller TP, et al. Among authors: jones se. Semin Hematol. 1988 Apr;25(2 Suppl 2):17-22. Semin Hematol. 1988. PMID: 2456619

5

Bisantrene hydrochloride in gastric adenocarcinoma: a Southwest Oncology Group Study.

Panettiere FJ, Jones SE, Oishi N, Eyre HJ, O'Bryan RM, Andes WA, Taylor SA, Grozea PN. Panettiere FJ, et al. Among authors: jones se. Med Pediatr Oncol. 1986;14(2):78-80. doi: 10.1002/mpo.2950140204. Med Pediatr Oncol. 1986. PMID: 3713640

6

A phase II study of bisantrene in malignant lymphomas. A Southwest Oncology Group Study.

Miller TP, Cowan JD, Neilan BA, Jones SE. Miller TP, et al. Among authors: jones se. Cancer Chemother Pharmacol. 1986;16(1):67-9. doi: 10.1007/BF00255289. Cancer Chemother Pharmacol. 1986. PMID: 3940222

7

Conclusions from clinical trials of the Southwest Oncology Group.

Jones SE, Coltman CA Jr, Grozea PN, DePersio EJ, Dixon DO. Jones SE, et al. Cancer Treat Rep. 1982 Apr;66(4):847-53. Cancer Treat Rep. 1982. PMID: 6176321 Clinical Trial.

8

Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group Study.

Jones SE, Grozea PN, Metz EN, Haut A, Stephens RL, Morrison FS, Talley R, Butler JJ, Byrne GE Jr, Hartsock R, Dixon D, Salmon SE. Jones SE, et al. Cancer. 1983 Mar 15;51(6):1083-90. doi: 10.1002/1097-0142(19830315)51:6<1083::aid-cncr2820510619>3.0.co;2-m. Cancer. 1983. PMID: 6185212 Clinical Trial.

9

Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.

Jones SE, Haut A, Weick JK, Wilson HE, Grozea P, Fabian CJ, McKelvey E, Byrne GE Jr, Hartsock R, Dixon DO, Coltman CA Jr. Jones SE, et al. Cancer. 1983 Apr 15;51(8):1339-47. doi: 10.1002/1097-0142(19830415)51:8<1339::aid-cncr2820510803>3.0.co;2-8. Cancer. 1983. PMID: 6186355 Clinical Trial. No abstract available.

10

Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.

Garewal HS, Brooks RJ, Jones SE, Miller TP. Garewal HS, et al. Among authors: jones se. J Clin Oncol. 1983 Dec;1(12):772-5. doi: 10.1200/JCO.1983.1.12.772. J Clin Oncol. 1983. PMID: 6422004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters